High quality research reports across a broad range of industries

The Seasonal Vaccines Market Will Experience Solid Growth from 2015–2025

The global seasonal influenza vaccine market, which for the purposes of this report comprises the 7MM (7MM – The US, France, Germany, Italy, Spain, UK, and Japan), generated about $3.1 billion in sales in 2015. GlobalData expects this market to experience solid growth, reaching sales of $4.3 billion by 2025 at a compound annual growth rate (CAGR) of 3.3%. The majority of this growth will occur in the 5EU, driven by the uptake of egg-based quadrivalent vaccines as the older and less expensive trivalent vaccines are gradually phased out. The seasonal influenza vaccines market in the 5EU is expected to grow at a CAGR of 5.5%, reaching sales of $1.0 billion by 2025. GlobalData estimates sales in the US to grow moderately at a CAGR of 3.5% during the next 10 years, reaching $2.6 billion by 2025, while Japan will experience less pronounced growth, posting a CAGR of 0.3%.

Key highlights from the report:

Pharma Giants Flex their Marketing and Manufacturing Capabilities to Expand their Market Shares